Latest news
Lupin Q1 Review: Broad-Based Growth Impresses, But Systematix Sees US Competition Ahead — Check Target Price - NDTV ProfitNDTV Profit · Mon, 10 Aug 2026 04:39:29 GMTSBI Q1 Review: Brokerages Raise Target Prices After Broad-Based Beat - NDTV ProfitNDTV Profit · Mon, 10 Aug 2026 02:12:56 GMTWhat to know about the first mRNA-based flu shot approved by the FDA - The Washington PostThe Washington Post · Thu, 06 Aug 2026 02:27:45 GMT